Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
7.21M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
138K
-
Shares change
-
+52.9K
-
Total reported value, excl. options
-
$99.5K
-
Value change
-
+$33.8K
-
Number of buys
-
6
-
Number of sells
-
-5
-
Price
-
$0.72
Significant Holders of BIO KEY INTERNATIONAL INC - Common Stock, $0.0001 par value per share (BKYI) as of Q3 2025
14 filings reported holding BKYI - BIO KEY INTERNATIONAL INC - Common Stock, $0.0001 par value per share as of Q3 2025.
BIO KEY INTERNATIONAL INC - Common Stock, $0.0001 par value per share (BKYI) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 138K shares
of 7.21M outstanding shares and own 1.92% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (36.9K shares), GEODE CAPITAL MANAGEMENT, LLC (32.6K shares), CITADEL ADVISORS LLC (25.7K shares), RENAISSANCE TECHNOLOGIES LLC (20.5K shares), XTX Topco Ltd (18.8K shares), Tower Research Capital LLC (TRC) (1.77K shares), UBS Group AG (1.42K shares), SBI Securities Co., Ltd. (300 shares), BANK OF AMERICA CORP /DE/ (53 shares), and HARBOUR INVESTMENTS, INC. (6 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.